Navigation Links
Bedford Laboratories(TM) Announces the Acquisition of CAFCIT(R) (Caffeine Citrate) Injection CAFCIT(R) (Caffeine Citrate) Oral Solution
Date:1/3/2008

/p>

Boehringer Ingelheim Corporation based in Ridgefield, CT, is the US headquarters to seven subsidiaries and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and approximately 38,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2006, Boehringer Ingelheim posted net sales of US $13.3 billion (10.6 billion euro) while spending approximately one-fifth of net sales in its largest business, segment Prescription Medicines, on research and development.

For more information, please visit. http://us.boehringer-ingelheim.com .


'/>"/>
SOURCE Bedford Laboratories
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Alma Lasers Announces Proposed Initial Public Offering
2. Smart Balance Announces Conversion of Convertible Preferred Stock
3. IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
4. MQ Associates, Inc. Announces Cash Tender Offer for 121/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Related Consent Solicitation
5. Heska Announces Amended Agreement With AgriLabs
6. Versus Technology Announces Fourth Quarter Results
7. FASgen Announces New Research Discoveries in Lung Cancer
8. Boston Scientific Announces CE Mark Approval for Next-Generation Cardiac Resynchronization Therapy Defibrillator
9. KV Pharmaceutical Company Announces NYSE Listing Extension
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
11. Transition Therapeutics Announces Appointment of Vice-President of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
...S Board, TORONTO, April 21 /PRNewswire-FirstCall/...der of products and services to the global life,sc...pivy, Partner at,ValueAct Capital, and Mr. William...look forward to benefiting from the,breadth of exp...
...lp or neck appear less likely to survive for five ...s, according to a report in the April issue of Arc...rnals. , Melanoma rates continue to increase whil...rognosis has been debated for decades, the authors...
...ing focus on hospital-physician ... /PRNewswire/ - The Deloitte Forensic Center repor...tions continues to get more,complex for hospitals...., that hospitals or the physicians,they enter into...
...ouncil is pleased to announce that the winner of t...Human Rights is Dr. Binayak Sen of Raipur,Chhattis...sh a hospital serving poor mine,workers in the reg...r nearly a year without trial as a result of,alleg...
...ncies diagnosed on face, ears, study finds , ... deadly melanoma skin cancers occur on the scalp a...apel Hill (UNC) study. , Researchers analyzed 51,7...where on the body, including the face or ears. , T...
...tion, BIRMINGHAM, Ala., April 21 Surgical Care A...ayek has been named president and,chief executive ...dent and,chief executive officer, Mike Snow, is re... served as president of VillageHealth Inc., an,ins...
Other Medicine News:Health News:MDS Appoints Two New Directors 2Health News:MDS Appoints Two New Directors 3Health News:Survival rates appear lower for scalp and neck melanoma than for other sites 2Health News:Video: Antifraud Compliance Getting More Complex for Hospitals 2Health News:Video: Antifraud Compliance Getting More Complex for Hospitals 3Health News:Video: Antifraud Compliance Getting More Complex for Hospitals 4Health News:Video: Antifraud Compliance Getting More Complex for Hospitals 5Health News:Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights 2Health News:Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights 3Health News:Melanomas on Scalp and Neck More Deadly 2Health News:SCA Names Andrew Hayek as New President and CEO 2
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 1New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 2New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 3New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 4New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 5New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 6Hobby Lobby Selects Concentra to Open Health Center 62350 1Hobby Lobby Selects Concentra to Open Health Center 62350 2Hobby Lobby Selects Concentra to Open Health Center 62350 3US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 1US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 2US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 3
...rst study evaluating DUROS(R) continuous delivery ..., , HAYWARD, Calif., April 24 Intarcia Therapeut...t accrual to a phase 1b clinical study evaluating ...e). The study is being conducted at multiple cente... of 44 patients with type 2 diabetes for a period ...
...votal Trial Expected to Initiate in 2010 for Blina...asdaq: MITI ), a biopharmaceutical company devel...ent of cancer, inflammation and autoimmune disease...ancial analysts at The Yale Club of New York City....areas of development across Micromet,s BiTE antibo...
Other Medicine Technology:Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 2Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 3Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 2Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 3Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 4
... Orthosis Until now, laborious custom fabrication ...tability was limited and modifications in response...d cumbersome.,The GunSlinger evolved from two yea...ching hospital. This orthosis can be quickly adjus...
...gned for the functional management of grade I, II,...e-inflated aircell, the brace provides focused, pn... while supporting the arm and shoulder. A detachab...additional arm support and helps to unload the wai...
...to treat or help prevent lower extremity disorder..., foot drop, contractures and pressure necrosis at...s a comfortable wicking interface for the patient....ed into a vertical configuration when not needed o...
... ankle. This simple concept is the cornerstone of ... you lock the heel with our patent-pending Stablel...d comfort your patient will experience walking in ...the heel and supports the posterior aspect of the ...
Medicine Products: